The drug company Sandoz Inc., maker of Zantac, has issued a voluntary recall after confirming that the generic Zantac capsules contained an “unexpected impurity, N-Nitrosodimethylamine (NDMA),” which is a probable human carcinogen.
The drug company Sandoz Inc., maker of Zantac, has issued a voluntary recall after confirming that the generic Zantac capsules contained an “unexpected impurity, N-Nitrosodimethylamine (NDMA),” which is a probable human carcinogen.